Panacur Suspension 10% 100 mg Suspension is a Health Canada–registered veterinary drug (DIN 00489875) held by Intervet Canada Corp, containing Fenbendazole. Health Canada lists its status as Marketed (status date 31 Aug 2000). Nexara Health has matched 13 registrations of Fenbendazole across 3 other regulated markets.
Health Canada registration
| DIN | 00489875 |
|---|---|
| Brand name | Panacur Suspension 10% |
| Active ingredient | Fenbendazole |
| Strength | 100 mg |
| Dosage form | Suspension |
| Route | Oral |
| Company | Intervet Canada Corp |
| Status | Marketed — 31 Aug 2000 |
| Class | Veterinary |
| ATC | |
| AHFS | 56:12.00 |
| Regulator record | Health Canada DPD entry · Product monograph |
Fenbendazole registered in other markets
13 registrations of the same molecule in 3 national registries outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| European Union (EMA) | Cunitraxx | Avimedical B.V. | Application withdrawn | EMA centrally authorised | ||
| European Union (EMA) | Panacur AquaSol | — | Authorised | EMA centrally authorised | ||
| Malaysia | Fenbenzole 10% w/v Oral Suspension | Vision Biotech Sdn Bhd | Veterinary | PRODUCT APPROVED | NPRA | |
| Malaysia | Fenzole (Fenbendazole Oral Suspension 10% w/v) | KM Vet Pharm Sdn. Bhd. | Veterinary | PRODUCT APPROVED | NPRA | |
| Malaysia | Gallifen 200mg/ml suspension for use in drinking water for chicken | Pahang Pharmacy Sdn. Bhd. | Veterinary | PRODUCT APPROVED | NPRA | |
| Malaysia | PAN-CURE Dewormer 4 % Premix Powder | Weissen Company (m) Sdn. Bhd. | Veterinary | PRODUCT APPROVED | NPRA | |
| Malaysia | PVP- Fenbendazole 10% w/v Suspension | Pelangi Vet Pharma Sdn. Bhd. | Veterinary | PRODUCT APPROVED | NPRA | |
| United States | Fenbendazole | Alivira Animal Health Limited | Powder | FDA NDC | ||
| United States | Fenbendazole | Medisca Inc. | Powder | FDA NDC | ||
| United States | Fenbendazole | Shaanxi Hanjiang Pharmaceutical Group Co., Ltd. | Powder | FDA NDC | ||
| United States | Fenbendazole | Kalchem International inc | Powder | FDA NDC | ||
| United States | Fenbendazole 222 MG | B & L Healthcare Products INC | Capsule | listed | FDA NDC | |
| United States | PREPAKU FENBENDAZOLE Canine Dewormer | Shenzhen Zhenshangzekai Technology Co., Ltd. | Granule | listed | FDA NDC |
See every manufacturer of Fenbendazole worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. Because this DIN is marketed in Canada, supply normally comes through the Canadian channel; where the Canadian presentation is short or discontinued, the registrations above show which regulated markets hold an equivalent that can be imported under the Special Access Programme or for clinical comparator use. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Panacur Suspension 10% (DIN 00489875) marketed in Canada?
Yes. Health Canada lists DIN 00489875 as Marketed as of 31 Aug 2000.
Who holds the Canadian licence for this product?
Intervet Canada Corp is the company of record in the Health Canada Drug Product Database.
Is Fenbendazole registered outside Canada?
Yes — Nexara Health has matched 13 registrations in 3 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 00489875, status date 2000-08-31; national medicine registries: EMA centrally authorised, FDA NDC, NPRA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 00489875, status date 2000-08-31; national medicine registries: EMA centrally authorised, FDA NDC, NPRA.
Health Canada Drug Product Database (DPD), DIN 00489875, status date 2000-08-31; national medicine registries: EMA centrally authorised, FDA NDC, NPRA. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.